Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-07-09

FDA Approved: CLONAZEPAM — Supplemental Application (Solco Healthcare LLC)

View source ↗

Summary

FDA granted a supplemental approval for clonazepam from Solco Healthcare LLC under ANDA077856.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonazepam (Clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)